SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-018146
Filing Date
2017-03-31
Accepted
2017-03-31 16:02:41
Documents
87
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v461049_10k.htm 10-K 1249988
2 EXHIBIT 23.1 v461049_ex23-1.htm EX-23.1 2597
3 EXHIBIT 31.1 v461049_ex31-1.htm EX-31.1 10215
4 EXHIBIT 31.2 v461049_ex31-2.htm EX-31.2 10307
5 EXHIBIT 32 v461049_ex32.htm EX-32 5422
  Complete submission text file 0001144204-17-018146.txt   8074368

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acur-20161231.xml EX-101.INS 1871085
7 XBRL TAXONOMY EXTENSION SCHEMA acur-20161231.xsd EX-101.SCH 76591
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20161231_cal.xml EX-101.CAL 59875
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20161231_def.xml EX-101.DEF 434758
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20161231_lab.xml EX-101.LAB 535275
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20161231_pre.xml EX-101.PRE 505499
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 17730295
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences